ISIN | LU0996778642 |
---|---|
Valor Number | 58920661 |
Bloomberg Global ID | |
Fund Name | Kieger Sustainable Healthcare Fund Class A USD Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 209.14 USD | 23.12.2024 |
---|---|---|
Previous Price * | 207.18 USD | 20.12.2024 |
52 Week High * | 239.55 USD | 30.08.2024 |
52 Week Low * | 205.80 USD | 27.12.2023 |
NAV * | 209.14 USD | 23.12.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 321,090,275 | |
Unit/Share Assets *** | 275,713,820 | |
Trading Information SIX |
YTD Performance | +1.26% |
29.12.2023 - 23.12.2024
29.12.2023 23.12.2024 |
---|---|---|
YTD Performance (in CHF) | +8.13% |
29.12.2023 - 23.12.2024
29.12.2023 23.12.2024 |
1 month | -4.57% |
25.11.2024 - 23.12.2024
25.11.2024 23.12.2024 |
3 months | -10.02% |
23.09.2024 - 23.12.2024
23.09.2024 23.12.2024 |
6 months | -6.85% |
24.06.2024 - 23.12.2024
24.06.2024 23.12.2024 |
1 year | +1.62% |
27.12.2023 - 23.12.2024
27.12.2023 23.12.2024 |
2 years | +9.19% |
23.12.2022 - 23.12.2024
23.12.2022 23.12.2024 |
3 years | -1.26% |
23.12.2021 - 23.12.2024
23.12.2021 23.12.2024 |
5 years | +35.66% |
27.12.2019 - 23.12.2024
27.12.2019 23.12.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UnitedHealth Group Inc | 6.41% | |
---|---|---|
Eli Lilly and Co | 5.30% | |
AstraZeneca PLC | 4.92% | |
Thermo Fisher Scientific Inc | 4.80% | |
Merck & Co Inc | 4.56% | |
Abbott Laboratories | 4.54% | |
Novartis AG Registered Shares | 4.42% | |
Intuitive Surgical Inc | 3.84% | |
Novo Nordisk AS Class B | 3.50% | |
Vertex Pharmaceuticals Inc | 3.37% | |
Last data update | 30.09.2024 |
TER *** | 0.99% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.98% |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |